Tradestie Institutional Equity Comparison Engine

ENSC vs CELU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while CELU counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus CELU at N/M Forward P/E and -254.0% operating margin (-5.3% YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
ENSC 0.8x vs CELU N/M Fwd P/E
Growth & Margin Winner CELU
Op Margin -281.3% vs -254.0% ยท YoY -15.1% vs -5.3%
Momentum & Technical Winner ENSC
1Y -80.3% vs -72.6% ยท 52W Pos 8% vs 2%
Options & Structure Winner CELU
UNCLASSIFIED (N/A IV) vs BREAKDOWN (50th %ile IV)
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0
CELU NASDAQ
Celularity Inc. Class A Common Stock
Pharmaceutical Preparations
$0.46
-1.05% 1D
Market Cap $15.2M
1M Return -55.9%
1Y Return -72.6%
Forward P/E N/M
Unified AI Score
42.9 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 67.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENSC -80.33% CELU -72.6% Spread: +7.73 pp (CELU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENSC Revenue CELU Revenue ENSC Op. Margin CELU Op. Margin Margin Edge
FY2020 $0M $10M -41.0% -1064.0% ENSC
FY2021 $0M $20M -562.7% -511.2% CELU
FY2022 $0M $20M -959.9% -142.4% CELU
FY2023 $0M $20M -480.5% -844.4% ENSC
FY2024 $10M $50M -129.2% -70.7% CELU
FY2025 $10M $30M -202.1% -230.9% ENSC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENSC (6) vs CELU (3)
Institutional Metric ENSC CELU Criterion Row Winner
Market Capitalization Scale $7.0M $15.2M Larger Scale Tie
Trailing P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Forward P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Revenue Growth (YoY) Growth -15.1% -5.3% Higher Growth CELU
Operating Margin (TTM) Profitability -281.3% -254.0% Higher Margin CELU
Net Profit Margin Profitability -280.5% -245.7% Higher Margin CELU
Return on Equity (ROE) Capital Efficiency -1295.1% -6367.2% Higher ROE ENSC
52-Week Range Position Momentum 8% ($0โ€“$2) 2% ($0โ€“$3) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 0.98ฮฒ ยท 79% Vol 2.01ฮฒ ยท 135% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 53.4 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENSC vs CELU Buy Guide
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CELU BREAKDOWN
60d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CELU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENSC nor CELU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.